<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5660">
  <stage>Registered</stage>
  <submitdate>10/07/2011</submitdate>
  <approvaldate>10/07/2011</approvaldate>
  <nctid>NCT01943708</nctid>
  <trial_identification>
    <studytitle>Novel Auto-continuous Positive Airway Pressure (CPAP) Validation</studytitle>
    <scientifictitle>A Study to Validate a Novel Auto Continuous Positive Airway Pressure Therapy</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>FPH-SA-10-07</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Sleep Apnea, Obstructive</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - SPAP
Treatment: devices - CPAP

Active Comparator: Continuous positive airway pressure (CPAP) device. - Standard CPAP therapy

Experimental: Auto-CPAP device (SPAP). - Novel Auto-CPAP algorithm


Treatment: devices: SPAP
Novel Auto-algorithm for Auto-CPAP device

Treatment: devices: CPAP
Standard CPAP therapy

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>AHI - The apnea hypopnea index (AHI) is a measure of sleep disordered breathing. It will be measured and compared between the two groups. The units are number of events per hour.</outcome>
      <timepoint>one post study night (once PSG is scored)</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Aged =18 years with mild-to-severe OSA (Apnea Hypopnea Index equal to or greater than
             5 per hour).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Any medical condition which contraindicates (see Appendix A) the use of CPAP or
             AutoCPAP.

          -  Unstable cardiovascular disease (untreated or resistant hypertension acceptable).

          -  Unstable psychiatric disease.

          -  Other significant sleep disorder.

          -  Inability to tolerate CPAP due to nasal obstruction or claustrophobia, as determined
             by the investigation investigator.

          -  Any known factor or disease that might interfere with treatment compliance,
             investigation conduct or interpretation of the results such as psychiatric disease,
             history of non compliance to medical regimens, or unwillingness to comply with
             investigational requirements.

          -  Participation in another clinical trial in the previous month.

          -  Less than 2 hours recorded sleep in either arm</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/09/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>74</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/10/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Fisher and Paykel Healthcare</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This single-blind randomised crossover trial aims to compare the efficacy of a novel
      Auto-CPAP algorithm (SPAP) to conventional CPAP. Up to 50 patients will be recruited from an
      OSA population, aged over 18.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01943708</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>